Search Results - "Gardovskis, J."

Omadacycline for Acute Bacterial Skin and Skin-Structure Infections by O’Riordan, William, Green, Sinikka, Overcash, J. Scott, Puljiz, Ivan, Metallidis, Symeon, Gardovskis, J, Garrity-Ryan, Lynne, Das, Anita F, Tzanis, Evan, Eckburg, Paul B, Manley, Amy, Villano, Stephen A, Steenbergen, Judith N, Loh, Evan

“…Treatment for acute bacterial skin and skin-structure infections is becoming more challenging as organisms with antimicrobial resistance become more prevalent…”
Get full text

Efficacy and safety of delafloxacin compared with vancomycin plus aztreonam for acute bacterial skin and skin structure infections: a Phase 3, double-blind, randomized study by Pullman, J, Gardovskis, J, Farley, B, Sun, E, Quintas, M, Lawrence, L, Ling, R, Cammarata, S

“…Delafloxacin is an investigational anionic fluoroquinolone in development for oral or intravenous administration for the treatment of infections caused by…”
Get full text

A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review by Loza, P, Irmejs, A, Daneberga, Z, Miklasevics, E, Berga-Svitina, E, Subatniece, S, Maksimenko, J, Trofimovics, G, Tauvena, E, Ukleikins, S, Gardovskis, J

“…Several recent studies in the Baltic region have found extended spectrum of pathogenic variants (PV) of the BRCA1/2 genes. The aim of current study is to…”
Get full text

Corrigendum re “21 – Urine exosomal miRNA profiles implicate the key role of TP53 in bladder cancer development” [Eur Urol Open Sci 2022;40(Suppl 1):S31–2] by Bitina-Barlote, E., Plonis, J., Vasiļonoks, J.K., Vjaters, E., Gardovskis, J., Daneberga, Z., Miklaševičs, E., Nakazawa-Miklaševiča, M.

Get full text

High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population by Maksimenko, J, Irmejs, A, Trofimovičs, G, Bērziņa, D, Skuja, E, Purkalne, G, Miklaševičs, E, Gardovskis, J

“…Pathogenic founder mutations (c.4035delA, c.5266dupC) contribute to 3.77% of all consecutive primary breast cancers and 9.9% of all consecutive primary ovarian…”
Get full text

Detection of allelic variants of the POLE and POLD1 genes in colorectal cancer patients by Pätzold, LA, Bērziņa, D, Daneberga, Z, Gardovskis, J, Miklaševičs, E

“…Incidence of colorectal cancer is high worldwide and it mostly occurs as an accumulation of environmental factors and genetic alterations. Hereditary…”
Get full text

509 Intercostobrachial Nerve Role in the Postmastectomy Pain Syndrome by Bokums, K, Irmejs, A, Gardovskis, J

Get full text

MC13-0081 Cell cycle regulatory proteins in pancreatic cancer by Simtniece, Z, Strumfa, I, Abolins, A, Vanags, A, Pavars, M, Vasko, E, Gardovskis, J

Get full text

285: MicroRNA expression in triple-negative versus other subtypes of breast cancer by Kalniete, D, Nakazawa-Miklasevica, M, Strumfa, I, Abolins, A, Irmejs, A, Trofimovics, G, Gardovskis, J, Miklasevics, E

Get full text

Impact of KRAS variant rs61764370 on breast cancer morbidity by Ustinova, M, Daneberga, Z, Bērziņa, D, Nakazawa-Miklaševiča, M, Maksimenko, J, Gardovskis, J, Miklaševičs, E

“…Low-penetrance gene variants and their combinations are topical study objects in breast cancer pathogenesis. Single nucleotide polymorphism rs61764370,…”
Get more information

The CHEK2 del5395 is a founder mutation without direct effects for cancer risk in the latvian population by Plonis, J, Kalniete, D, Nakazawa-Miklasevica, M, Irmejs, A, Vjaters, E, Gardovskis, J, Miklasevics, E

“…Our objective was to determine: 1) whether the checkpoint kinase 2 ( ) del5395 (g.27417113-27422508 del, NC_000022.11) is a founder mutation in the Latvian…”
Get full text

Survival rates of familial and sporadic prostate cancer patients by Plonis, J, Nakazawa-Miklasevica, M, Malevskis, A, Vaganovs, P, Pildava, S, Vjaters, E, Gardovskis, J, Miklasevics, E

“…To compare cancer-specific survival rates for familial and sporadic prostate cancer patients. Gleason score and age at diagnosis of familial group and sporadic…”
Get more information

262 Overall Survival of BRCA1-associated Breast Cancer is Better Than Predicted by Adjuvant! Online and PREDICT: a Hospital-based Study in Latvia by Plakhins, G, Irmejs, A, Gardovskis, A, Subatniece, S, Liepniece-Karele, I, Purkalne, G, Teibe, U, Trofimovics, G, Miklasevics, E, Gardovskis, J

Get full text

Lynch syndrome mutations shared by the Baltic States and Poland by Dymerska, D., Kurzawski, G., Suchy, J., Roomere, H., Toome, K., Metspalu, A., Janavičius, R., Elsakov, P., Irmejs, A., Berzina, D., Miklaševičs, E., Gardovskis, J., Rebane, E., Kelve, M., Kładny, J., Huzarski, T., Gronwald, J., Dębniak, T., Byrski, T., Stembalska, A., Surdyka, D., Siołek, M., Szwiec, M., Banaszkiewicz, Z., Wiśniowski, R., Kilar, E., Scott, R.J., Lubiński, J.

Get full text

A comparison of quality of life and postoperative results from combined PPH and conventional haemorrhoidectomy in different cases of haemorrhoidal disease by Martinsons, A., Narbuts, Z., Brunenieks, I., Pavars, M., Lebedkovs, S., Gardovskis, J.

“…Objective  To compare the early postoperative results and late patient‐related postoperative results by a Short‐Form 36 quality of life survey after…”
Get full text

P126 Mucinous breast cancer: Morphological and immunohistochemical characterisation by Abolins, A, Strumfa, I, Melbarde-Gorkusa, I, Vanags, A, Trofimovics, G, Gardovskis, J

Get full text

Assessment of life quality factors by breast cancer patients by Pranka, M., Dzervite, A., Rungule, R., Lace, T., Miklasevics, E., Gardovskis, J.

“…The aim of the article is to present the results of a sociological investigation with the aim to analyze the research data on subjective and objective life…”
Get full text

P149 Evaluation of family histories and analysis of BRCA1 founder mutations in a population-based series of breast and ovarian cancer cases in Latvia by Plakhins, G, Irmejs, A, Gardovskis, A, Subatniece, S, Rozite, S, Teibe, U, Trofimovics, G, Miklasevics, E, Gardovskis, J

Get full text

Novel germline MLH1 and MSH2 mutations in Latvian Lynch syndrome families by Bērziņa, D, Irmejs, A, Kalniete, D, Borošenko, V, Nakazawa-Miklaševiča, M, Rībenieks, K, Trofimovičs, G, Gardovskis, J, Miklaševičs, E

“…Hereditary non-polyposis colorectal cancer or Lynch syndrome is an autosomal dominantly inherited disease with high penetrance, mostly due to mutations in the…”
Get more information

Von Hippel-Lindau Syndrome : Diagnosis and Management of Hemangioblastoma and Pheochromocytoma by Vaganovs, P., Bokums, K., Miklaševics, E., Plonis, J., Zarina, L., Geldners, I., Gardovskis, J., Vjaters, E.

“…Introduction. Von Hippel-Lindau (VHL) syndrome is a pathological condition that causes various clinical symptoms and is difficult to diagnose. The most common…”
Get full text